rs797044807
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_022167.4(XYLT2):c.520del(p.Ala174ProfsTer35) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Consequence
XYLT2
NM_022167.4 frameshift
NM_022167.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.674
Genes affected
XYLT2 (HGNC:15517): (xylosyltransferase 2) The protein encoded by this gene is an isoform of xylosyltransferase, which belongs to a family of glycosyltransferases. This enzyme transfers xylose from UDP-xylose to specific serine residues of the core protein and initiates the biosynthesis of glycosaminoglycan chains in proteoglycans including chondroitin sulfate, heparan sulfate, heparin and dermatan sulfate. The enzyme activity, which is increased in scleroderma patients, is a diagnostic marker for the determination of sclerotic activity in systemic sclerosis. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-50354012-TG-T is Pathogenic according to our data. Variant chr17-50354012-TG-T is described in ClinVar as [Pathogenic]. Clinvar id is 207978.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XYLT2 | NM_022167.4 | c.520del | p.Ala174ProfsTer35 | frameshift_variant | 2/11 | ENST00000017003.7 | NP_071450.2 | |
XYLT2 | XM_005257572.5 | c.424del | p.Ala142ProfsTer35 | frameshift_variant | 2/11 | XP_005257629.1 | ||
XYLT2 | XM_047436522.1 | c.-72del | 5_prime_UTR_variant | 2/11 | XP_047292478.1 | |||
XYLT2 | NR_110010.2 | n.535del | non_coding_transcript_exon_variant | 2/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XYLT2 | ENST00000017003.7 | c.520del | p.Ala174ProfsTer35 | frameshift_variant | 2/11 | 1 | NM_022167.4 | ENSP00000017003 | P1 | |
XYLT2 | ENST00000376550.7 | c.520del | p.Ala174ProfsTer35 | frameshift_variant, NMD_transcript_variant | 2/10 | 1 | ENSP00000365733 | |||
XYLT2 | ENST00000507602.5 | c.520del | p.Ala174ProfsTer35 | frameshift_variant | 2/10 | 2 | ENSP00000426501 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 33
GnomAD4 exome
Cov.:
33
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Spondylo-ocular syndrome Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City | Sep 26, 2019 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 04, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at